Sipai Health Technology Co (FRA:AX1) PE Ratio: At Loss (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:AX1 Sipai Health Technology Co Ltd FRA:AX1
64 GF Score
Price €0.14
GF Value €0.22
! 5 Warning Signs
View Full Analysis

What is Sipai Health Technology Co PE Ratio?

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-08-20), Sipai Health Technology Co's share price is €0.139. Sipai Health Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.03. Therefore, Sipai Health Technology Co's PE Ratio for today is At Loss.

Sipai Health Technology Co's EPS (Diluted) for the six months ended in Dec. 2025 was €-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.03.

As of today (2026-08-20), Sipai Health Technology Co's share price is €0.139. Sipai Health Technology Co's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.02. Therefore, Sipai Health Technology Co's PE Ratio without NRI ratio for today is At Loss.

Sipai Health Technology Co's EPS without NRI for the six months ended in Dec. 2025 was €-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.02.

During the past 3 years, the average EPS without NRI Growth Rate was 76.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 46.50% per year.

During the past 7 years, Sipai Health Technology Co's highest 3-Year average EPS without NRI Growth Rate was 76.40% per year. The lowest was -150.50% per year. And the median was 45.45% per year.

Sipai Health Technology Co's EPS (Basic) for the six months ended in Dec. 2025 was €-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.03.

Back to Basics: PE Ratio


Sipai Health Technology Co  (FRA:AX1) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Sipai Health Technology Co PE Ratio Related Terms


Sipai Health Technology Co PE Ratio Historical Data

* Premium members only.

The historical data trend for Sipai Health Technology Co's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sipai Health Technology Co PE Ratio Chart

Sipai Health Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio
Get a 7-Day Free Trial N/A N/A At Loss At Loss At Loss

Sipai Health Technology Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

FRA:AX1 vs MCK, COR, CAH: PE Ratio Comparison

For the Medical Distribution subindustry, Sipai Health Technology Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sipai Health Technology Co PE Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Sipai Health Technology Co's PE Ratio falls into.


FRA:AX1
64GF Score
Sipai Health Technology Co Ltd FRA:AX1
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sipai Health Technology Co PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Sipai Health Technology Co's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=0.139/-0.025
=-5.56(At Loss)

Sipai Health Technology Co's Share Price of today is €0.139.
For company reported semi-annually, Sipai Health Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.03.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Is Sipai Health Technology Co (FRA:AX1) Overvalued in 2026?

Based on GuruFocus' analysis, Sipai Health Technology Co stock appears to be undervalued. The current stock price of €0.14 is trading 36.8% below its estimated GF Value™ of €0.22.

Key valuation signals for FRA:AX1:

  • PE Ratio: At Loss
  • GF Value™: €0.22 vs. price of €0.14 (36.8% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the FRA:AX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sipai Health Technology Co Business Description

Other Exchanges 00314:Hong Kong
Address 128 Tianmu West Road, 1603-1605A, 16th Floor, Tower 1, Kerry Enterprise Center, Jing\'an District, Shanghai, CHN
Sipai Health Technology Co Ltd is a medical technology and health management company in China. The company has three reportable operating segments: Specialty Pharmacy Business - engaged in the operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Commercial Insurance Services Business - rendering insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. The company generates key revenue from the Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
64GF Score

Get the complete analysis for FRA:AX1

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.14
Price
€0.22
GF Value